Related Experiment Video
Updated: Apr 16, 2026

07:47
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.4K
EHR-based phenome wide association study in pancreatic cancer
Tomasz Adamusiak1, Mary Shimoyama2
1Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI.
Summary
Researchers developed a new method using electronic health records (EHR) to generate hypotheses for pancreatic cancer. Phenome-wide association studies identified 231 clinical concepts linked to patient death, aiding early detection research.
Area of Science:
- Computational biology
- Medical informatics
- Oncology
Background:
- Pancreatic cancer is a leading cause of cancer mortality in the U.S. with poor prognosis.
- Early detection remains a significant challenge in managing pancreatic cancer.
- Novel methods are needed for effective clinical hypothesis generation.
Purpose of the Study:
- To present a novel method for large-scale clinical hypothesis generation.
- To utilize phenome-wide association studies (PheWAS) on Electronic Health Records (EHR) data.
- To identify clinical concepts associated with mortality in a pancreatic cancer cohort.
Main Methods:
- A cohort of 1,154 pancreatic cancer patients from 2004-2013 was analyzed.
- Over 2.5 million structured clinical observations from EHRs formed the phenome.
- Pairwise associations between 10,164 clinical concepts and patient death were tested.
Main Results:
- After correcting for multiple testing, 231 clinical concepts showed significant association with death.
- This suggests a link between various clinical observations and pancreatic cancer mortality.
- The findings highlight potential areas for further investigation.
Conclusions:
- Phenome-wide association studies (PheWAS) are a viable method for rapid hypothesis generation.
- Leveraging structured EHR data combined with knowledge engineering is effective.
- This approach can accelerate discoveries in pancreatic cancer research.

